|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Multriple-dose pharmacokinetics of telmisartan and of hydrochlorothiazide following concurrent administration in healthy subjects 显示文摘 | Yong CL Dias VC Stangier J | 2000 | J Clin Phannacol2000，，： | 1 |
| 2 | Absorption,Metabolism,and excretion of intravenously and orally administeredtel misartan in healthy volunteers显示文摘 | Stangier J schmid J Turck D | 2000 | Jcoin Pharmacol2000，40，12： | 1 |
| 3 | Pharmacokinetics of single-dose telmisartan 120 mg given during and between hemodialysis in subjects with severe renal insufficiency:comparison with healthy volunteers显示文摘 | STANGIER J SU C-APF BRICKL R | 2000 | J Clin Pharmacol2000，40，121： | 1 |
| 4 | Idarucizumab, a specific antidote for dabigatran: immediate, complete and sustained reversal of dabigatran induced anticoagulati6n in elderly and renally impaired subjects 显示文摘 | Glund S Stangier J Schmohl M | 2014 | Blood2014，124，： | 1 |
| 5 | The pharmacokinetics, pharma- codynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects 显示文摘 | Stangier J Rathgen K Stahle H | 2007 | Br J Clin Pharmacol2007，64，： | 1 |
| 6 | Dabigatran etexilate-a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity 显示文摘 | van Ryn J Stangier J Haertter S | 2010 | Thromb Haemost2010，103，： | 1 |
| 7 | Dabigatran : an oral novel potent reversible nonpeptide inhibitor of thrombin 显示文摘 | Eisert WG Hauel N Stangier J | 2010 | Arterioscler Thromb Vasc Biol2010，30，10： | 1 |
| 8 | Dabigatran etexilate-a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity显示文摘 | Van Ryn J Stangier J Haertter S | 2010 | Thromb Haemost2010，103，6： | 1 |
| 9 | Clinical pharmacokinetics and pharmaco- dynamics of the oral direct thrombin inhibitor dabigatrane- texilate显示文摘 | STANGIER D J | 2008 | Clin Pharmacokinet2008，47，5： | 1 |
| 10 | Review on telmisartan: a novel long-acting angiotensinⅡ receptor antagonist显示文摘 | Wienen W Entzeroth M van Meel JCA Stangier J Busch U Ebner T | 2000 | Cardiovasc Drug Rev2000，18，： | 1 |
| 11 | The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral di- rect thrombin inhibitor,in healthy male subjeets显示文摘 | Stangier J Rathgen K Stahle H | 2007 | Br J Clin Pharmacol2007，64，3： | 1 |
| 12 | Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate显示文摘 | STANGIER J | 2008 | Clin Pharmacokinet2008，47，5： | 1 |
| 13 | Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate显示文摘 | Stangier J | 2008 | Clin Pharmacokinet2008，47，5： | 1 |
| 14 | The phalmacokinetics, pharmacodynamics and tolerability of dabigatran ctexilate, a new oral direct thrombin inhibitor, in healthy rome subjects 显示文摘 | Stangier J Rathgen K Staehle H | 2007 | Br J Clin Pharmacol2007，64，3： | 1 |
| 15 | Pharmacokinetics of single-dose telmisartan 120 mg given during and between hemodialysis in subjects with severe renal insufficiency: comparison with healthy volunteers 显示文摘 | Stangier J Chung-An PF Su Brickl R | 2000 | J Clin Pharmacol2000，40，： | 1 |
| 16 | Orcokinin: A novel myotropic peptide from the nervous system of the cray- fish, Orconectes limosus显示文摘 | Stangier J Hilbich C Burdzik S | 1992 | Peptides1992，13，： | 1 |
| 17 | Pharmacology, pharmacokinetics, and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor 显示文摘 | STANGIER J CLEMENS A | 2009 | Clin Appl Thromb Hemost2009，15，1： | 1 |
| 18 | Absorption,metabolism, and excretion of intravenously and orally administered Telmisartan in healthy volunteers显示文摘 | Stangier J Schmid J Turck D | 2000 | J Clin Pharmacol2000，40，： | 1 |
| 19 | Absorption, metabolism and excretion of intravenously and orally administered telmisartan in healthy volunteers显示文摘 | STANGIER SCHMID J | 2000 | J Clin Pharmacol2000，40，12： | 1 |
| 20 | Dabigatran etexilate-a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity显示文摘 | VAN RYN J STANGIER J HAERTTER S | 2010 | ThrombHaemost2010，103，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员